The bonds will be issued by Biocon Biologics Global plc which is a wholly owned subsidiary of BBL and will be backed by a strong security package, the company said.
Investors should raise cash by up to 10% as Trump tariffs roil markets: Axis Securities
Axis Securities advises investors to increase cash holdings by up to 10% and selectively buy high-quality stocks amid market volatility from U.S. tariffs on Indian